查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470765

医院感染控制市场：按类型、适应症和最终用户划分 - 全球预测 2024-2030

Hospital Acquired Infection Control Market by Type, Indication, End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年医院感染控制市场规模为342.6亿美元，2024年达363.9亿美元，预计2030年将达532亿美元，复合年增长率为6.48%。

医院获得性感染（HAI）控制是指医疗机构为预防和控制医院和其他医疗机构收治的病人感染疾病而采取的系统方法和奉献精神。这些感染疾病是由于接触各种微生物（例如细菌、病毒、真菌和其他病原体）而发生的。这些措施涵盖广泛的策略，包括严格的卫生习惯、灭菌和消毒程序、个人防护工具(PPE) 的使用、感染疾病监测以及遵守侵入性操作和抗生素管理通讯协定。医疗保健环境中对感染疾病的认识不断提高，加上对感染控制政策的迅速重视，正在推动市场成长。然而，在资源有限的环境中，与先进感染控制技术相关的高成本可能令人望而却步。此外，灭菌和消毒流程的技术进步以及环保高效消毒剂的开发正在为製造商创造重大机会。

主要市场统计
基准年[2023] 342.6亿美元
预测年份 [2024] 363.9亿美元
预测年份 [2030] 532亿美元
复合年增长率（%） 6.48%

透过类型诊断和测试设备的不断技术进步提高效率

诊断和实验室设备是识别和管理医院获得性感染 (HAI) 的重要组成部分。此领域包括用于在临床环境中快速检测病原体的设备和套件。该设备利用聚合酵素链锁反应（PCR）和酵素结合免疫吸附检测法（ELISA）等先进技术，有助于早期诊断和监测感染，以便及时干预和治疗。消毒产品在防止医疗机构内感染传播方面发挥着至关重要的作用。消毒产品包括各种化学和非化学製剂，旨在破坏或惰性各种表面上的传染性生物体。其中包括消毒剂、灭菌剂和防腐剂，用于医疗设备、医院病床和其他高接触区域，以保持无菌环境并最大限度地降低感染传播的风险。手部卫生产品对于对抗 HAI 至关重要，因为手部感染是感染传播的主要途径。此类别包括抗菌洗手液、洗手液和消毒剂，其配方可有效杀死细菌并防止有害细菌在医护人员、患者和访客的手上繁殖。个人防护工具(PPE) 是保护医护人员和病患免于接触传染源的服装和装备。个人防护装备包括口罩、罩衣、面罩等，可作为防止感染疾病传播的屏障。个人防护装备至关重要，尤其是在高传染性疾病爆发期间，有助于减少医院感染的传播并保护医疗机构中个人的健康。灭菌设备，包括高压釜、热灭菌器和冷灭菌器，对于医疗器械和医疗设备的无病原体至关重要。循环时间、容量和能源效率等因素将决定您的偏好。

最终使用者医院和 ICU 重视针对高风险环境的全面自动化解决方案。

门诊手术和诊断中心的特点是为手术和诊断程序提供短期患者护理。由于患者吞吐量高且週转时间短，这些中心的 HAI 控制需求主要集中在高效的灭菌设备和方法上。医院和加护病房（ICU）是治疗重症患者的中心设施，预防医院感染至关重要。这些设施需要全面的感染控制解决方案，包括空气过滤、表面消毒和严格的灭菌通讯协定。儘管疗养院和妇产中心的患者人口统计不同，但他们通用担心患者容易感染 HAI。这些环境中的感染控制强调温和而有效的消毒方法和可安全长期接触的产品。

区域洞察

以美国和加拿大为代表的美洲地区由于严格的监管标准和高水准的医疗保健支出，对 HAI 缓解解决方案表现出强劲的需求。创新和技术进步是关键因素，重点是无毒环保的消毒方法和智慧监控系统。在欧盟 (EU)，严格的法规以及对医疗保健认证和品质的关注正在推动对高品质 HAI 管理解决方案的需求。这项欧盟范围内的倡议旨在协调感染控制实践，加强医院感染研究的跨国合作并促进创新。中东的医疗保健正在经历转型，在医院基础设施和品质改进计划方面进行了大量投资。对先进感染控制技术的需求不断增长，一些国家更喜欢具有成本效益的解决方案。由于医疗基础设施的成长和感染预防通讯协定意识的提高，亚太地区有望快速采用先进的医院感染管理解决方案。中国和日本是亚太地区在研发方面投入大量资金的重要国家，而印度由于医院数量不断增加以及对医疗保健品质的重视，正在成为一个重要的市场。该地区的客户购买行为倾向于提供成本效益和有效性的整合解决方案。

FPNV定位矩阵

FPNV定位矩阵对于评估医院感染控制市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对医院感染控制市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.医院感染控制市场的市场规模与预测是多少？

2.在医院感染控制市场的预测期内，需要考虑投资哪些产品、细分市场、应用和领域？

3.医院感染控制市场的技术趋势和法规结构是什么？

4.医院感染控制市场主要厂商的市场占有率为何？

5.进入医院感染控制市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医疗机构对感染的认识不断提高，感染控制政策变得越来越重要。
      • 随着人口老化的加剧，慢性病盛行率也随之增加
      • 医疗保健行业中消毒剂和医用不织布的使用增加
    • 抑制因素
      • 与内视镜再处理设备和微生物检测设备相关的高成本
    • 机会
      • 加大研发投入，增加医院耗材使用量
      • 灭菌消毒製程和感染控制设备的技术进步
    • 任务
      • 对再处理仪器安全性的担忧
  • 市场区隔分析
    • 类型：诊断和测试设备的持续技术进步以提高效率
    • 最终使用者：医院和 ICU 重视针对高风险环境的全面且自动化的解决方案。
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章医院感染控制市场：按类型

  • 诊断和测试设备
  • 消毒产品
  • 手部卫生产品
  • 个人防护设备
  • 消毒器

第七章 医院感染控制市场适应症

  • 血流感染疾病
  • 困难梭状桿菌感染疾病
  • 院内肺炎
  • 多重抗药性细菌
  • 手术部位感染
  • 尿道感染

第八章医院感染控制市场：依最终用户分类

  • 门诊手术/诊断中心
  • 医院及重症监护室
  • 疗养院和产科中心

第九章北美和南美医院感染控制市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太医院感染控制市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲医院感染控制市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Alstrom 推出新一代同步灭菌套件“Reliance Fusion”
    • PAMA推出新型环氧乙烷消毒溶液
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-035590447FE4

[194 Pages Report] The Hospital Acquired Infection Control Market size was estimated at USD 34.26 billion in 2023 and expected to reach USD 36.39 billion in 2024, at a CAGR 6.48% to reach USD 53.20 billion by 2030.

Hospital acquired infection (HAI) control refers to the systematic approach and dedicated efforts undertaken by healthcare institutions to prevent and manage infections acquired by patients during their stay in hospitals & other healthcare facilities. These infections can occur as a result of exposure to various microbial agents, including bacteria, viruses, fungi, and other pathogens. The control measures span a wide range of strategies, including rigorous hygiene practices, sterilization and disinfection procedures, use of personal protective equipment (PPE), surveillance of infections, and adherence to protocols for invasive procedures and antibiotic stewardship. The rising awareness about infections acquired in healthcare settings, coupled with a rapidly growing emphasis on infection control policies, boosts the market growth. However, high costs associated with advanced infection control technologies can be prohibitive for resource-limited settings. Furthermore, technological advancements in sterilization and disinfection processes, along with the development of eco-friendly and more efficient disinfectants, pose significant opportunities to the manufacturers.

KEY MARKET STATISTICS
Base Year [2023] USD 34.26 billion
Estimated Year [2024] USD 36.39 billion
Forecast Year [2030] USD 53.20 billion
CAGR (%) 6.48%

Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency

Diagnostic and testing equipment constitute critical components in the identification and management of hospital-acquired infections (HAIs). This segment includes devices and kits used for the rapid detection of pathogens in clinical settings. Leveraging advanced technologies, such as polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA), this equipment helps in the early diagnosis and monitoring of infections, enabling timely intervention and treatment. Disinfection products play a pivotal role in preventing the spread of infections within healthcare facilities. Disinfection products encompass a wide range of chemical and non-chemical agents designed to destroy or inactivate infectious organisms on various surfaces. Among these are disinfectants, sterilants, and antiseptics, which are used on medical equipment, hospital beds, and other high-touch areas to maintain a sterile environment and minimize the risk of infection transmission. Hand hygiene products are essential in the battle against HAIs, given that hand transmission is a major pathway for the spread of infections. This category includes antibacterial hand washes, hand rubs, and sanitizers, which are formulated to effectively kill germs and prevent the colonization of harmful bacteria on the hands of healthcare workers, patients, and visitors. Personal Protective Equipment (PPE) consists of garments and gear designed to protect healthcare workers and patients from being exposed to infectious agents. PPE includes items such as masks, gowns, and face shields, which act as barriers to the transmission of infections. Especially crucial during outbreaks of highly contagious diseases, PPE is instrumental in reducing the spread of HAIs and safeguarding the health of individuals within the healthcare environment. Sterilization equipment encompasses autoclaves, heat sterilizers, and low-temperature sterilizers, crucial for rendering medical instruments and devices pathogen-free. Factors such as cycle time, capacity, and energy efficiency govern their preference.

End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments

Ambulatory surgical & diagnostic centers are characterized by their short-term patient care for surgical and diagnostic procedures. The need for HAI control in these centers focuses on efficient sterilization equipment and practices, given the high throughput of patients and the necessity for quick turnaround times. Hospitals and Intensive Care Units (ICUs) are the epicenters for treating critical patients, making HAI prevention paramount. These facilities require comprehensive infection control solutions that encompass air filtration, surface disinfection, and stringent sterilization protocols. Nursing homes and maternity centers, while differing in patient demographics, share concerns over the vulnerability of their populations to HAIs. Infection control in these settings emphasizes gentle yet effective disinfection methods and products that are safe for long-term exposure.

Regional Insights

The Americas, led by the United States and Canada, exhibit a robust demand for HAI control solutions, attributed to stringent regulatory standards and a high level of healthcare expenditure. Innovation and technological advancement are key factors, with a focus on non-toxic, eco-friendly disinfection methods and smart monitoring systems. In the European Union, stringent regulations and a focus on accreditation and quality in healthcare drive the demand for high-standard HAI control solutions. EU-wide initiatives aim at harmonizing infection control practices, enhancing cross-border cooperation in HAI research, and fostering innovation. The Middle East is witnessing a healthcare transformation, with significant investments in hospital infrastructure and quality improvement initiatives. There is an increasing demand for advanced infection control technologies, albeit with a preference for cost-effective solutions in some countries. The Asia Pacific region is noted for its rapid adoption of advanced HAI control solutions, driven by growing healthcare infrastructure and heightened awareness of infection-prevention protocols. China and Japan are prominent countries in APAC with substantial investments in R&D, while India is emerging as a substantial market due to its increasing number of hospitals and focus on healthcare quality. Customer purchasing behavior in this region leans towards integrated solutions offering both cost efficiency and effectiveness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hospital Acquired Infection Control Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hospital Acquired Infection Control Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., AHLSTROM OYJ, Becton, Dickinson and Company, Belimed AG, Cantel Medical Corporation by STERIS PLC, Cardinal Health, Inc., DNV AS, Ecolab Inc., F. Hoffmann-La Roche Ltd, GOJO Industries, Inc., Henkel AG & Co. KGaA, Kimberly-Clark Corporation, Medline Industries, LP, Olympus Corporation, Sterigenics International LLC, and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Diagnostic & Testing Equipment
    • Disinfection Products
    • Hand Hygiene Products
    • Personal Protective Equipment
    • Sterilization Equipment
  • Indication
    • Bloodstream Infections
    • Clostridioides difficile Infections
    • Hospital-acquired Pneumonia
    • Multidrug-Resistant Organisms
    • Surgical Site Infections
    • Urinary Tract Infections
  • End-user
    • Ambulatory Surgical & Diagnostic Centers
    • Hospitals & ICUs
    • Nursing Homes & Maternity Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hospital Acquired Infection Control Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hospital Acquired Infection Control Market?

3. What are the technology trends and regulatory frameworks in the Hospital Acquired Infection Control Market?

4. What is the market share of the leading vendors in the Hospital Acquired Infection Control Market?

5. Which modes and strategic moves are suitable for entering the Hospital Acquired Infection Control Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
      • 5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
      • 5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
      • 5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with the safety of reprocessed instruments
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
    • 5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Hospital Acquired Infection Control Market, by Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Testing Equipment
  • 6.3. Disinfection Products
  • 6.4. Hand Hygiene Products
  • 6.5. Personal Protective Equipment
  • 6.6. Sterilization Equipment

7. Hospital Acquired Infection Control Market, by Indication

  • 7.1. Introduction
  • 7.2. Bloodstream Infections
  • 7.3. Clostridioides difficile Infections
  • 7.4. Hospital-acquired Pneumonia
  • 7.5. Multidrug-Resistant Organisms
  • 7.6. Surgical Site Infections
  • 7.7. Urinary Tract Infections

8. Hospital Acquired Infection Control Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical & Diagnostic Centers
  • 8.3. Hospitals & ICUs
  • 8.4. Nursing Homes & Maternity Centers

9. Americas Hospital Acquired Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Hospital Acquired Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Hospital Acquired Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
    • 12.3.2. PAMA introduces new ethylene oxide sterilisation solution
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
  • FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 281. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 293. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 296. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023